John Scales Centre for Biomedical Engineering, Institute of Orthopaedics and Musculoskeletal Science, Division of Surgery and Interventional Science, University College London, Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, Middlesex HA7 4LP, United Kingdom.
J Bone Joint Surg Am. 2013 Sep 4;95(17):1569-75. doi: 10.2106/JBJS.L.00362.
The objective of this study was to examine the degree of osteointegration into a hydroxyapatite-coated collar and relate this finding to aseptic loosening in patients with a distal femoral replacement used to treat primary bone cancer. Our hypothesis was that the implant collar would increase osteointegration and reduce the rate of aseptic implant loosening.
Sixty-one patients treated with a primary cemented distal femoral prosthesis between 1992 and 2001 were included in this study. The mean duration of follow-up was 8.5 years (range, two to eighteen years). Extracortical bone growth into the grooved hydroxyapatite-coated collar was quantified radiographically. Histological sections through four hydroxyapatite-coated collars and four implants with no collar, retrieved following amputation due to local recurrence or at autopsy at a mean of 3.5 years (range, 1.4 to 6.1 years) after implantation, were evaluated as well.
Five (8%) of the implants were revised because of aseptic loosening, 3% of the implants fractured, and 3% were revised because of infection. Six limbs (10%) required amputation because of local tumor recurrence. On radiographs, osteointegration into the collar was seen to have occurred in 70% of the patients and did not correlate with sex, age, diagnosis, or length of time postoperatively. Histological analysis showed mature lamellar bone within the grooves of the hydroxyapatite-coated collar, and bone was observed in direct contact with the hydroxyapatite coating. Extracortical bone failed to make direct contact with the surface of the implants manufactured without a collar.
The use of cemented distal femoral massive bone tumor prostheses with a hydroxyapatite-coated collar located at the shoulder of the implant was followed by a low (8%) rate of revision due to aseptic loosening. The use of hydroxyapatite grooved collars may lead to osteointegration of the implant shoulder (collar) and may reduce the rate of aseptic loosening.
本研究旨在检查羟基磷灰石涂层颈圈的骨整合程度,并将此发现与治疗原发性骨肿瘤的股骨远端置换患者的无菌性松动相关联。我们的假设是,植入物颈圈会增加骨整合并降低无菌性植入物松动的发生率。
本研究纳入了 1992 年至 2001 年间接受初次骨水泥股骨远端假体治疗的 61 例患者。平均随访时间为 8.5 年(范围,2 至 18 年)。通过影像学定量评估外骨在带槽羟基磷灰石涂层颈圈中的生长情况。还评估了 4 个带羟基磷灰石涂层颈圈的组织学切片和 4 个无颈圈的植入物,这些植入物因局部复发或植入后平均 3.5 年(范围,1.4 至 6.1 年)进行截肢或尸检时取出。
5 例(8%)因无菌性松动而对植入物进行了修订,3%的植入物发生了骨折,3%的植入物因感染而进行了修订。6 条肢体(10%)因局部肿瘤复发而截肢。在影像学上,观察到 70%的患者发生了颈圈的骨整合,且该现象与性别、年龄、诊断或术后时间均无相关性。组织学分析显示,羟基磷灰石涂层颈圈的凹槽中存在成熟的板层骨,并且观察到骨与羟基磷灰石涂层直接接触。外骨未能与无颈圈制造的植入物表面直接接触。
使用带有位于植入物肩部的羟基磷灰石涂层颈圈的骨水泥股骨远端骨肿瘤假体,无菌性松动的翻修率较低(8%)。使用羟基磷灰石开槽颈圈可能会导致植入物肩部(颈圈)的骨整合,并可能降低无菌性松动的发生率。